These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1280318)

  • 1. Melioidosis: when in doubt leave the quinolone alone!
    Ashdown LR; Currie BJ
    Med J Aust; 1992 Sep; 157(6):427-8. PubMed ID: 1280318
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of five fluoroquinolones against 71 isolates of Burkholderia pseudomallei.
    Ho PL; Cheung TK; Kinoshita R; Tse CW; Yuen KY; Chau PY
    J Antimicrob Chemother; 2002 Jun; 49(6):1042-4. PubMed ID: 12039903
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of sparfloxacin against selected enterobacteriaceae and pseudomonaceae including Ps. pseudomallei (melioidosis).
    Siristonpun Y; Rojnapisarnvong V; Srimuang S; Tanphaichitra D
    J Chemother; 1995 Nov; 7 Suppl 4():54-5. PubMed ID: 8904106
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.
    Chan YY; Ong YM; Chua KL
    Antimicrob Agents Chemother; 2007 Feb; 51(2):623-30. PubMed ID: 17145801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melioidosis: antibiogram of cases in Singapore 1987-2007.
    Tan AL; Tan ML
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S101-2. PubMed ID: 19121668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Melioidosis].
    Miyagi K; Saito A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():428-33. PubMed ID: 12722256
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
    Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of cathelicidin peptides against Burkholderia pseudomallei, the causative agent of melioidosis.
    Sim SH; Liu Y; Tan J; Thong TW; Wang D; Ooi EE; Tan G
    Int J Antimicrob Agents; 2011 Sep; 38(3):270-1. PubMed ID: 21782393
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Treatment of Localized Cutaneous Melioidosis with Oral Antibiotic Therapy Alone.
    Smith S; Hanson J
    Am J Trop Med Hyg; 2019 May; 100(5):1039-1040. PubMed ID: 31088604
    [No Abstract]   [Full Text] [Related]  

  • 10. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.
    Hemarajata P; Baghdadi JD; Hoffman R; Humphries RM
    J Clin Microbiol; 2016 Dec; 54(12):2866-2873. PubMed ID: 27654336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
    Jenney AW; Lum G; Fisher DA; Currie BJ
    Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
    Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Series Study of Melioidosis, Colombia.
    Rodríguez JY; Morales-López SE; Rodríguez GJ; Álvarez-Moreno CA; Esquea K; Pinzon H; Ramirez LR; Moreno L; Ocampo W; Cepeda ML
    Emerg Infect Dis; 2019 Aug; 25(8):1531-4. PubMed ID: 31310232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: how important is this combination in maintenance therapy of melioidosis?
    Saraya S; Soontornpas C; Chindavijak B; Mootsikapun P
    Indian J Med Microbiol; 2009; 27(1):88-9. PubMed ID: 19172079
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous melioidosis: report of a case].
    Li Q; Zeng HM; Zhang HJ
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):767-8. PubMed ID: 17374271
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibiotics of choice for the treatment of melioidosis in Indian set up.
    Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
    Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.